Arthritis Research & Therapy
-
Publication Venue For
-
Transgenic conversion of ω-6 to ω-3 polyunsaturated fatty acids via fat-1 reduces the severity of post-traumatic osteoarthritis..
22:83.
2020
-
A consensus-based framework for conducting and reporting osteoarthritis phenotype research..
22:54.
2020
-
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice..
21:292.
2019
-
Meta-analysis of pain and function placebo responses in pharmacological osteoarthritis trials..
21:173.
2019
-
Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation..
21:146.
2019
-
Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes..
20:283.
2018
-
Obesity alters the in vivo mechanical response and biochemical properties of cartilage as measured by MRI..
20:232.
2018
-
Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial..
20:174.
2018
-
Ten weeks of high-intensity interval walk training is associated with reduced disease activity and improved innate immune function in older adults with rheumatoid arthritis: a pilot study..
20:127.
2018
-
Association between general joint hypermobility and knee, hip, and lumbar spine osteoarthritis by race: a cross-sectional study..
20:76.
2018
-
The biological functions of DNA: from the sublime to the slime..
19:275.
2017
-
Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability..
19:12.
2017
-
The role of mitochondria in immune-mediated disease: the dangers of a split personality..
18:169.
2016
-
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies..
18:156.
2016
-
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls..
18:86.
2016
-
The effectiveness of low-level laser therapy for nonspecific chronic low back pain: a systematic review and meta-analysis..
17:360.
2015
-
Rheumatoid vasculitis: going, going, but not yet gone..
17:116.
2015
-
Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis..
16:R134.
2014
-
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients..
16:R63.
2014
-
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout..
16:R60.
2014
-
Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome..
16:R51.
2014
-
Gout, tophi and the wonders of NETs.
16:431.
2014
-
Gout, tophi and the wonders of NETs..
16:431.
2014
-
Tumor necrosis factor: is it time to change the name?.
16:108.
2014
-
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy..
15:R137.
2013
-
The Choosing Wisely initiative: does it have your back?.
15:117.
2013
-
The butterfly rash of lupus: an example of aposematism?.
15:106.
2013
-
Cancer risk in childhood-onset systemic lupus..
15:R198.
2013
-
Genome-wide expression profiles of subchondral bone in osteoarthritis..
15:R190.
2013
-
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease..
15 Suppl 1:S1.
2013
-
Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma..
15:R188.
2013
-
The 2013 ACR meeting: mad macs at the Marina..
15:130.
2013
-
The effectors of innate immunity: DAMPs, DAMEs, or DIMEs?.
15:123.
2013
-
4th International Forum on Rheumatoid Arthritis: Great times near the Great Wall..
14:125.
2012
-
The LE cell: crime scene or crime stopper?.
14:120.
2012
-
Kinematic and dynamic gait compensations resulting from knee instability in a rat model of osteoarthritis..
14:R78.
2012
-
HMGB1: a smoking gun in lupus nephritis?.
14:112.
2012
-
The BRIC-GARN Meeting 2011: of mice and men..
14:107.
2012
-
Kinematic and dynamic gait compensations in a rat model of lumbar radiculopathy and the effects of tumor necrosis factor-alpha antagonism..
13:R137.
2011
-
Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?.
13:109.
2011
-
Central pain contributions in osteoarthritis: next steps for improving recognition and treatment?.
13:133.
2011
-
Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration..
13:R187.
2011
-
Pus: the Rodney Dangerfield of immunology..
13:131.
2011
-
Quantification of the whole-body burden of radiographic osteoarthritis using factor analysis..
13:R176.
2011
-
The 2011 ACR meeting: what's new in the Windy City..
13:138.
2011
-
Type I interferon pathway in adult and juvenile dermatomyositis..
13:249.
2011
-
Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254)..
12:R229.
2010
-
Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice..
12:R130.
2010
-
Amino acid racemization reveals differential protein turnover in osteoarthritic articular and meniscal cartilages..
11:R34.
2009
-
Microparticles as biomarkers in autoimmunity: from dust bin to center stage..
11:135.
2009
-
Post-translational aging of proteins in osteoarthritic cartilage and synovial fluid as measured by isomerized aspartate..
11:R55.
2009
-
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis..
10:R94.
2008
-
Complement and arthritis: another step in understanding..
10:104.
2008
-
Developments in the scientific understanding of lupus..
10:218.
2008
-
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease..
10:209.
2008
-
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase..
8:R12.
2006
-
Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures..
8:R140.
2006
-
B cells in rheumatoid synovitis..
7 Suppl 3:S9-12.
2005